INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Imperial College commences mRNA cancer therapy trial in UK—it made me sick to my stomach...

Imperial College commences mRNA cancer therapy trial in UK—it made me sick to my stomach...

...Moderna and UK Government experiementing with peoples lives.

Hedley Rees's avatar
Hedley Rees
Feb 14, 2024
∙ Paid
39

Share this post

INSIDE PHARMA
INSIDE PHARMA
Imperial College commences mRNA cancer therapy trial in UK—it made me sick to my stomach...
16
7
Share

Imperial College Healthcare NHS Trust has commenced dosing patients

Subscribers may remember my posting how MHRA had been the only regulatory authority in the world to allow mRNA therapies to be cooked up in hospitals, with no skills in manufacture. This is the post, and below you can see they are doing it—sponsored by Moderna!

UKs Point of Care Manufacture is another trojan horse for gene therapies

Hedley Rees
·
February 23, 2023
UKs Point of Care Manufacture is another trojan horse for gene therapies

On the surface, this seems an excellent idea This new initiative from UK Government seems an excellent idea: Government response to consultation on proposals to support the regulation of medicines manufactured at the Point of Care. This is how it’s described:

Read full story

Imperial College commences mRNA cancer therapy trial in UK

When I read it, I could have thrown up. This is how the article begins:

Imperial College Healthcare NHS Trust has commenced dosing of the first subjects in the UK with experimental messenger ribonucleic acid (mRNA) therapy, mRNA-4359, in a Phase I/II clinical trial to treat solid tumours, including melanoma and lung cancer. This immunotherapy is designed to trigger the immune system of the patient by presenting common tumour markers.

An 81-year-old man from Surrey, diagnosed with treatment-resistant malignant melanoma, was the first UK recipient of mRNA-4359.

It is sponsored by Moderna, which plans to enrol s…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share